Association between ultra-low level soluble p24 and adverse clinical outcomes in virologically-suppressed people with HIV (SpARROW)

Project
Valutazione della proteina p24 come predittore di esiti clinici avversi in una coorte di persone con HIV virologicamente soppresse.

Overview

Contributors

MARCHETTI GIULIA CARLA   Scientific Manager  

Departments involved

Type

INTLI - Finanziamenti internazionali

Funder

EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES - ESCMID
External Organization Funding Organization

Date/time interval

September 1, 2025 - August 31, 2026

Project duration

12 months

Research Areas

Concepts